Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Ashitaba (Angelica keiskei), a revered leafy green native to Japan, is notable for its high concentration of bioactive chalcones like xanthoangelol and 4-hydroxyderricin, which exhibit rapid oral absorption and significant systemic bioavailability. These compounds contribute to its potent anti-inflammatory, antioxidant, and metabolic health benefits, supporting its traditional use for vitality and longevity.
Reported Benefits (Provisional)
Origin & History
Angelica keiskei, commonly known as Ashitaba, is a herbaceous perennial plant native to the Pacific coast of Japan, particularly the Izu Islands. It is now cultivated in Southeast Asia and other temperate regions globally. Revered for its rapid regenerative growth, Ashitaba is a nutrient-dense superfood valued for its cellular protective and metabolic benefits.
Research Narrative (Provisional)
Modern research, including clinical studies, supports Ashitaba's efficacy in antioxidant and anti-inflammatory mechanisms. Phytopharmacological studies have further elucidated its medicinal uses and pharmacological benefits. Preliminary evidence also suggests roles in cellular regeneration and metabolic support.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Vitamins: A, C, E, B12 - Minerals: Potassium, Calcium, Magnesium - Phytochemicals/Bioactives: Chalcones (Xanthoangelol, 4-hydroxyderricin), Flavonoids, Coumarins, Polyphenols, Chlorophyll - Fiber
Reported Mechanism (Provisional)
The primary mechanisms of Ashitaba are attributed to its unique chalcone constituents, notably xanthoangelol and 4-hydroxyderricin. These chalcones exhibit rapid oral absorption, achieving peak plasma concentrations within 1-2 hours post-ingestion, and high systemic bioavailability, with studies indicating extensive distribution to various tissues. They modulate key cellular pathways, including inhibition of NF-κB activation, enhancement of Nrf2-mediated antioxidant defenses, and activation of AMPK, collectively contributing to its anti-inflammatory, antioxidant, and metabolic regulatory effects.
Clinical Narrative (Provisional)
Clinical evidence remains limited to preclinical studies, with one 52-week mouse study demonstrating significant reduction in age-induced PAI-1 increases and decreased TNF levels, though specific percentage reductions were not quantified. Anti-diabetic effects are supported by in vitro studies showing PTP1B inhibition and anti-hyperglycemic activity of purified chalcones. Most evidence derives from animal models and cell studies rather than human clinical trials. The research foundation is promising but requires human validation studies.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.